For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Assisted Reproductive Technology (ART) is the technology used to achieve pregnancy in procedures such as fertility medication, in vitro fertilization and surrogacy. It is reproductive technology used primarily for infertility treatments, and is also known as fertility treatment. It mainly belongs to the field of reproductive endocrinology and infertility, and may also include intracytoplasmic sperm injection (ICSI) and cryopreservation. Some forms of ART are also used with regard to fertile couples for genetic reasons (preimplantation genetic diagnosis). ART is also used for couples who are discordant for certain communicable diseases; for example, HIV to reduce the risk of infection when a pregnancy is desired.
Scope of the Report:
This report studies the Assisted Reproductive Technology (ART) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Assisted Reproductive Technology (ART) market by product type and applications/end industries.
North America is also expected to witness growth in the coming years. This is due to people awareness towards various fertility options, government support for the in-vitro fertilization and various technological and procedure up gradation. For instance, in August 2015 Ovascience's treatment named AUGMENT has been reported to have rejuvenated women's aging egg cells and provided benefits to eggs with poor quality. In February 2015, the scientist of U.S. who invented the three parent IVF procedure requested the Food and Drug Administration (FDA) to grant permission for its clinical trials as age related infertility.
The global Assisted Reproductive Technology (ART) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Assisted Reproductive Technology (ART).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Irvine Scientific
- Origio a/s
- Vitro Life
- Esco Micro Pte. Ltd.
- IVFtech ApS
- Research Instruments
- Genea Limited
- Smiths Medical
- Thermo Fisher Scientific, Inc.
- Cook Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Fresh Donor
- Fresh Nondonor
- Frozen Donor
- Frozen Nondonor
- Egg/Embryo bank
Market Segment by Applications, can be divided into
- Women Younger Than Age 35
- Women Older Than Age 35